Efficacy and safety of aldafermin in non-alcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials

Efficacy and safety of aldafermin in non-alcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials

<h3>Background</h3><p dir="ltr">Non-alcoholic steatohepatitis (NASH) is an advanced subtype of non-alcoholic fatty liver disease (NAFLD). NASH prevalence is increasing exponentially and carries a high risk for disease progression, cirrhosis, and liver-related mortality. A...

Full description

Saved in:
Bibliographic Details
Main Author: Mohamed Mahmoud Marey (18560902) (author)
Other Authors: Mohamed Belal (18560905) (author), Abdelaziz A. Awad (18560908) (author), Eslam Mohammed Rabea (18560911) (author), Malak A. Hassan (18560914) (author), Ahmed W. Abbas (18560917) (author), Abdulqadir J. Nashwan (11659453) (author)
Published: 2024
Subjects:
Biomedical and clinical sciences
Clinical sciences
NAFLD
NASH
Fatty liver
Aldafermin
FGF19
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items